Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer.

导出 OA

翻译打印收藏纠错

作者： Yusuke,Yoshimura ^[1] ; Naoki,Sawa ^[1] ; Shusaku,Matsuoka ^[2] ; Daisuke,Ikuma ^[1] ; Yuki,Oba ^[1] ; Akinari,Sekine ^[1] ; Eiko,Hasegawa ^[3] ; Hiroki,Mizuno ^[3] ; Masayuki,Yamanouchi ^[1] ; Tatsuya,Suwabe ^[1] ; Junichi,Hoshino ^[1] ; Kei,Kono ^[2] ; Keiichi,Kinowaki ^[1] ; Kenichi,Ohashi ^[2] ; Shigeo,Toda ^[4] ; Shuichiro,Matoba ^[4] ; Hideki,Wakui ^[4] ; Yoshifumi,Ubara ^[5]

作者单位： Nephrology Center, Toranomon Hospital Kajigaya, Japan. ^[1] Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan. ^[2] Nephrology Center, Toranomon Hospital, Japan. ^[3] Department of Pathology, Toranomon Hospital, Japan. ^[4] Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan. ^[5] Department of Gastroenterological Surgery, Toranomon Hospital, Japan. ^[6] Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan. ^[7] Department of Life Science, Graduate School of Engineering Science, Akita University, Japan. ^[8]

关键词 focal segmental glomerulosclerosis (FSGS) collapsing variant ramucirumab vascular endothelial growth factor receptor 2 antibody